MeMed logo
ECCMID 2001 LOGO
GettyImages-597587533-(2).jpg

Learn about MeMed's host

immune response technology at

ECCMID 2021

Online 9 - 12 July 2021

MeMed is transforming patient care by listening to the immune system and turning host response signals into clinical action.

Speaking on behalf of MeMed at the conference:

gruppe.jpg
Dr. Eran Eden
arrow

S116 Viral infections 

Observer “A host assay comprising TRAIL, IP-10 and CRP can improve antibiotic treatment decisions for viral PCR positive adults by accurately ruling out co-infection”

Dr. Eran Eden

Co-founder and CEO of MeMed

09 July 2021 - 19:25

Prof. Susanna Esposito
arrow

S36 Bacterial infection

Autopilot: “A host-based assay comprising TRAIL, IP-10 and CRP outperforms procalcitonin in accurately distinguishing bacterial from viral infections in febrile children” 

Prof. Susanna Esposito

Full Professor of Pediatrics

Prof. Susanna Esposito,  Full Professor of Pediatrics, Director of Pediatric Clinic, Pietro Barilla Children’s Hospital, Director of Specialization School in Pediatrics, Department of Medicine and Surgery, University

10 July 2021 - 17:25

A doctor treats children

About MeMed

At MeMed, a leader in host response technologies, we decode the body's complex signals into simple insights that improve people's lives. By leveraging our expertise in host-response profiling and machine-learning algorithms, we are creating a portfolio of tests that address tough clinical dilemmas.

 

Importantly, with the support of public and private partnerships, we have developed a point-of-need, rapid measurement platform called MeMed Key® to ensure timely availability of these novel tests during the clinician’s decision-making workflow.

A girl talking on the phone

Contact us